NASDAQ:ABAX - Abaxis Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$83.32 -0.40 (-0.48 %)
(As of 05/20/2018 08:19 AM ET)
Previous Close$83.32
Today's Range$83.11 - $83.98
52-Week Range$43.66 - $83.98
Volume523,541 shs
Average Volume419,643 shs
Market Capitalization$1.89 billion
P/E Ratio64.09
Dividend Yield0.77%
Beta1.19

About Abaxis (NASDAQ:ABAX)

Abaxis logoAbaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan profiles, which are packaged as single-use plastic veterinary reagent discs; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results. Further, it provides VetScan rapid tests for the detection of various diseases, as well as sells products developed through its patented Orbos discrete lyophilization process to companies for other applications. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.

Receive ABAX News and Ratings via Email

Sign-up to receive the latest news and ratings for ABAX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ABAX
CUSIP00256710
Phone510-675-6500

Debt

Debt-to-Equity RatioN/A
Current Ratio6.02
Quick Ratio5.02

Price-To-Earnings

Trailing P/E Ratio64.09
Forward P/E Ratio57.86
P/E Growth5.29

Sales & Book Value

Annual Sales$244.70 million
Price / Sales7.73
Cash Flow$1.6405 per share
Price / Cash50.79
Book Value$12.81 per share
Price / Book6.50

Profitability

EPS (Most Recent Fiscal Year)$1.29
Net Income$27.17 million
Net Margins11.11%
Return on Equity10.65%
Return on Assets9.12%

Miscellaneous

Employees584
Outstanding Shares22,700,000

Abaxis (NASDAQ:ABAX) Frequently Asked Questions

What is Abaxis' stock symbol?

Abaxis trades on the NASDAQ under the ticker symbol "ABAX."

How often does Abaxis pay dividends? What is the dividend yield for Abaxis?

Abaxis announced a quarterly dividend on Thursday, April 26th. Stockholders of record on Friday, June 1st will be given a dividend of $0.18 per share on Friday, June 15th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Thursday, May 31st. This is an increase from Abaxis's previous quarterly dividend of $0.16. View Abaxis' Dividend History.

How will Abaxis' stock buyback program work?

Abaxis declared that its board has initiated a stock repurchase program on Wednesday, October 25th 2017, which allows the company to repurchase $21,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's leadership believes its stock is undervalued.

How were Abaxis' earnings last quarter?

Abaxis (NASDAQ:ABAX) released its quarterly earnings results on Thursday, April, 26th. The medical research company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.32 by $0.10. The medical research company had revenue of $67.90 million for the quarter, compared to the consensus estimate of $66.02 million. Abaxis had a return on equity of 10.65% and a net margin of 11.11%. The firm's revenue was up 16.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.33 earnings per share. View Abaxis' Earnings History.

When is Abaxis' next earnings date?

Abaxis is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Abaxis.

What price target have analysts set for ABAX?

9 equities research analysts have issued 12-month price targets for Abaxis' shares. Their forecasts range from $48.00 to $65.00. On average, they expect Abaxis' share price to reach $57.8750 in the next year. View Analyst Ratings for Abaxis.

Who are some of Abaxis' key competitors?

Who are Abaxis' key executives?

Abaxis' management team includes the folowing people:
  • Mr. Clinton H. Severson, Chairman and Chief Exec. Officer (Age 70)
  • Mr. Donald P. Wood, Pres & COO (Age 66)
  • Mr. Ross Taylor Jr., CFO, Principal Accounting Officer, VP of Fin. & Sec. (Age 55)
  • Dr. Kenneth P. Aron Ph.D., Chief Technology Officer (Age 65)
  • Dr. Craig M. Tockman DVM, VP of Animal Health Sales and Marketing - North America (Age 58)

Has Abaxis been receiving favorable news coverage?

Media stories about ABAX stock have been trending positive recently, according to Accern. The research group rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Abaxis earned a daily sentiment score of 0.33 on Accern's scale. They also assigned media headlines about the medical research company an impact score of 48.99 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are Abaxis' major shareholders?

Abaxis' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (16.82%), BlackRock Inc. (13.92%), PRIMECAP MANAGEMENT COMPANY (9.77%), Dimensional Fund Advisors LP (3.13%), Wells Fargo & Company MN (2.96%) and Royal Bank of Canada (1.81%). Company insiders that own Abaxis stock include Achim Henkel, Clinton Severson, Craig Tockman, Donald Peter Wood, Kenneth Aron, Michael D Casey, Prithipal Singh and Richard Bastiani. View Institutional Ownership Trends for Abaxis.

Which institutional investors are selling Abaxis stock?

ABAX stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Echo Street Capital Management LLC, Royal Bank of Canada, Tiverton Asset Management LLC, Spark Investment Management LLC, Glen Harbor Capital Management LLC, Rhumbline Advisers and JPMorgan Chase & Co.. Company insiders that have sold Abaxis company stock in the last year include Achim Henkel, Craig Tockman, Donald Peter Wood, Kenneth Aron, Michael D Casey and Prithipal Singh. View Insider Buying and Selling for Abaxis.

Which institutional investors are buying Abaxis stock?

ABAX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Rockefeller Capital Management L.P., Kayne Anderson Rudnick Investment Management LLC, Pier Capital LLC, Federated Investors Inc. PA, Wells Fargo & Company MN, Millennium Management LLC and Engineers Gate Manager LP. View Insider Buying and Selling for Abaxis.

How do I buy shares of Abaxis?

Shares of ABAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Abaxis' stock price today?

One share of ABAX stock can currently be purchased for approximately $83.32.

How big of a company is Abaxis?

Abaxis has a market capitalization of $1.89 billion and generates $244.70 million in revenue each year. The medical research company earns $27.17 million in net income (profit) each year or $1.29 on an earnings per share basis. Abaxis employs 584 workers across the globe.

How can I contact Abaxis?

Abaxis' mailing address is 3240 WHIPPLE ROAD, UNION CITY CA, 94587. The medical research company can be reached via phone at 510-675-6500 or via email at [email protected]


MarketBeat Community Rating for Abaxis (ABAX)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  166 (Vote Outperform)
Underperform Votes:  291 (Vote Underperform)
Total Votes:  457
MarketBeat's community ratings are surveys of what our community members think about Abaxis and other stocks. Vote "Outperform" if you believe ABAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABAX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Abaxis (NASDAQ:ABAX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Abaxis in the last 12 months. Their average twelve-month price target is $57.8750, suggesting that the stock has a possible downside of 30.54%. The high price target for ABAX is $65.00 and the low price target for ABAX is $48.00. There are currently 1 sell rating, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 1 Sell Rating(s)
7 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $57.8750$56.6250$56.6250$47.6250
Price Target Upside: 30.54% downside11.79% downside11.79% downside3.44% downside

Abaxis (NASDAQ:ABAX) Consensus Price Target History

Price Target History for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2018Credit Suisse GroupUpgradeUnderperform ➝ NeutralLowView Rating Details
5/16/2018SidotiDowngradeBuy ➝ NeutralHighView Rating Details
4/27/2018Stifel NicolausBoost Price TargetHold ➝ Hold$57.00 ➝ $62.00HighView Rating Details
2/8/2018Bank of AmericaBoost Price TargetUnderperform ➝ Sell$46.00 ➝ $48.00MediumView Rating Details
1/29/2018Canaccord GenuityReiterated RatingHold$65.00LowView Rating Details
1/9/2018UBSUpgradeUnderperform ➝ Market PerformMediumView Rating Details
1/9/2018Raymond JamesUpgradeUnderperform ➝ Market PerformMediumView Rating Details
1/5/2018Northcoast ResearchUpgradeNeutral ➝ BuyHighView Rating Details
12/1/2017AegisReiterated RatingHoldHighView Rating Details
2/1/2017Seaport Global SecuritiesUpgradeBuyN/AView Rating Details
7/22/2016Feltl & Co.DowngradeHold ➝ SellN/AView Rating Details
(Data available from 5/20/2016 forward)

Earnings

Abaxis (NASDAQ:ABAX) Earnings History and Estimates Chart

Earnings by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Earnings Estimates

2018 EPS Consensus Estimate: $1.35
2019 EPS Consensus Estimate: $1.58
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.33$0.33$0.33
Q2 20181$0.38$0.38$0.38
Q3 20181$0.30$0.30$0.30
Q4 20181$0.34$0.34$0.34
Q1 20191$0.40$0.40$0.40
Q2 20191$0.42$0.42$0.42
Q3 20191$0.33$0.33$0.33
Q4 20191$0.43$0.43$0.43

Abaxis (NASDAQ ABAX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2018$0.35N/AView Earnings Details
4/26/2018Q4 2018$0.32$0.42$66.02 million$67.90 millionViewN/AView Earnings Details
1/25/2018Q3 2018$0.26$0.31$59.37 million$59.70 millionViewListenView Earnings Details
10/24/2017Q2 2018$0.27$0.29$60.85 million$58.90 millionViewN/AView Earnings Details
7/27/2017Q1 2018$0.33$0.28$60.37 million$58.26 millionViewN/AView Earnings Details
4/27/2017Q4 2017$0.3340$0.33$58.04 million$58.20 millionViewN/AView Earnings Details
1/26/2017Q317$0.31$0.30$54.36 million$52.80 millionViewN/AView Earnings Details
10/25/2016Q217$0.35$0.34$60.69 million$58.60 millionViewListenView Earnings Details
7/21/2016Q117$0.32$0.30$58.70 million$57.70 millionViewListenView Earnings Details
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details
10/21/2014Q215$0.23$0.24$50.55 million$53.90 millionViewListenView Earnings Details
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details
10/23/2012$0.18$0.18ViewN/AView Earnings Details
7/26/2012$0.17$0.13ViewN/AView Earnings Details
4/26/2012$0.16$0.21ViewN/AView Earnings Details
1/26/2012$0.16$0.13ViewN/AView Earnings Details
10/25/2011$0.14$0.15ViewN/AView Earnings Details
7/28/2011$0.16$0.10ViewN/AView Earnings Details
4/28/2011$0.16$0.15ViewN/AView Earnings Details
1/27/2011$0.18$0.17ViewN/AView Earnings Details
10/26/2010Q2 2011$0.17$0.17ViewN/AView Earnings Details
7/29/2010Q1 2011$0.16$0.16ViewN/AView Earnings Details
4/29/2010Q4 2010$0.17$0.12ViewN/AView Earnings Details
1/28/2010Q3 2010$0.17$0.15ViewN/AView Earnings Details
10/27/2009Q2 2010$0.17$0.14ViewN/AView Earnings Details
7/30/2009Q1 2010$0.14$0.17ViewN/AView Earnings Details
4/29/2009Q4 2009$0.17$0.12ViewN/AView Earnings Details
1/29/2009Q3 2009$0.16$0.15ViewN/AView Earnings Details
10/27/2008Q2 2009$0.16$0.15ViewN/AView Earnings Details
7/24/2008Q1 2009$0.16$0.12ViewN/AView Earnings Details
5/1/2008Q4 2008$0.16$0.15ViewN/AView Earnings Details
1/31/2008Q3 2008$0.16$0.14ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Abaxis (NASDAQ:ABAX) Dividend Information

Abaxis pays an annual dividend of $0.64 per share, with a dividend yield of 0.77%. ABAX's next quarterly dividend payment will be made on Friday, June 15. Abaxis pays out 49.61% of its earnings out as a dividend.
Next Dividend:6/15/2018
Annual Dividend:$0.64
Dividend Yield:0.77%
Payout Ratio(s):49.61% (Trailing 12 Months of Earnings)
44.44% (Based on This Year's Estimates)
37.21% (Based on Next Year's Estimates)
39.01% (Based on Cash Flow)
Dividend Payments by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/26/2018quarterly$0.180.99%5/31/20186/1/20186/15/2018
1/25/2018quarterly$0.160.91%2/28/20183/1/20183/15/2018
10/24/2017quarterly$0.161.28%11/30/201712/1/201712/15/2017
7/27/2017quarterly$0.141.19%8/30/20179/1/20179/15/2017
4/27/2017quarterly$0.141.24%5/30/20176/1/20176/15/2017
1/26/2017quarterly$0.141.13%2/27/20173/1/20173/15/2017
10/28/2016quarterly$0.141.17%11/29/201612/1/201612/15/2016
7/21/2016quarterly$0.121.04%8/30/20169/1/20169/15/2016
4/28/2016quarterly$0.121.06%6/1/20166/3/20166/17/2016
1/28/2016quarterly$0.111.01%3/1/20163/3/20163/17/2016
11/3/2015quarterly$0.110.84%12/1/201512/3/201512/17/2015
7/23/2015quarterly$0.110.9%9/1/20159/3/20159/17/2015
4/30/2015quarterly$0.110.79%6/2/20156/4/20156/18/2015
1/30/2015quarterly$0.100.65%2/27/20153/3/20153/17/2015
10/23/2014quarterly$0.100.82%11/13/201411/17/201412/16/2014
7/24/2014quarterly$0.100.86%8/29/20149/3/20149/17/2014
4/24/2014quarterly$0.105/30/20146/3/20146/17/2014
12/6/2012special$1.0012/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Abaxis (NASDAQ ABAX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.30%
Institutional Ownership Percentage: 99.28%
Insider Trading History for Abaxis (NASDAQ:ABAX)
Institutional Ownership by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ ABAX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/8/2018Achim HenkelDirectorSell6,000$68.06$408,360.0083,344View SEC Filing  
3/8/2018Michael D CaseyDirectorSell5,000$71.07$355,350.0027,290View SEC Filing  
3/6/2018Donald Peter WoodCOOSell10,000$68.99$689,900.00View SEC Filing  
3/6/2018Kenneth AronInsiderSell1,412$69.59$98,261.08View SEC Filing  
3/6/2018Prithipal SinghDirectorSell2,000$70.25$140,500.00View SEC Filing  
2/27/2018Achim HenkelInsiderSell3,600$69.08$248,688.0057,650View SEC Filing  
1/31/2018Craig TockmanVPSell1,650$74.33$122,644.5010,866View SEC Filing  
1/31/2018Prithipal SinghDirectorSell2,000$74.63$149,260.0044,000View SEC Filing  
5/26/2017Achim HenkelInsiderSell650$48.87$31,765.5058,950View SEC Filing  
5/8/2017Achim HenkelDirectorSell8,650$47.75$413,037.5068,150View SEC Filing  
2/2/2017Richard BastianiDirectorSell4,000$51.12$204,480.0049,178View SEC Filing  
12/6/2016Clinton SeversonCEOSell15,000$51.35$770,250.00562,300View SEC Filing  
12/2/2016Kenneth AronInsiderSell5,000$51.09$255,450.0092,151View SEC Filing  
9/9/2016Clinton SeversonCEOSell2,000$48.29$96,580.00574,691View SEC Filing  
9/8/2016Prithipal SinghDirectorSell1,000$49.50$49,500.0042,500View SEC Filing  
8/25/2016Prithipal SinghDirectorSell1,500$50.30$75,450.0043,500View SEC Filing  
8/24/2016Donald Peter WoodInsiderSell8,500$50.21$426,785.0052,618View SEC Filing  
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.0054,400View SEC Filing  
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.0053,609View SEC Filing  
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.0015,400View SEC Filing  
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.6116,303View SEC Filing  
12/8/2015Craig TockmanVPSell560$54.44$30,486.401,189View SEC Filing  
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.0010,400View SEC Filing  
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.0014,400View SEC Filing  
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00381,987View SEC Filing  
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.0064,330View SEC Filing  
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.0020,634View SEC Filing  
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Abaxis (NASDAQ ABAX) News Headlines

Source:
DateHeadline
Head-To-Head Review: Abaxis (ABAX) vs. Faro Technologies (FARO)Head-To-Head Review: Abaxis (ABAX) vs. Faro Technologies (FARO)
www.americanbankingnews.com - May 20 at 1:19 AM
Reviewing Abaxis (ABAX) and Cubic (CUB)Reviewing Abaxis (ABAX) and Cubic (CUB)
www.americanbankingnews.com - May 19 at 3:37 PM
Robbins Arroyo LLP: Acquisition of Abaxis, Inc. (ABAX) by Zoetis Inc. (ZTS) May Not Be in Shareholders Best InterestsRobbins Arroyo LLP: Acquisition of Abaxis, Inc. (ABAX) by Zoetis Inc. (ZTS) May Not Be in Shareholders' Best Interests
finance.yahoo.com - May 19 at 9:16 AM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of Abaxis, Inc. to Zoetis Inc. is Fair to ShareholdersINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of Abaxis, Inc. to Zoetis Inc. is Fair to Shareholders
www.businesswire.com - May 18 at 4:40 PM
WeissLaw LLP Investigates Abaxis Inc.WeissLaw LLP Investigates Abaxis Inc.
finance.yahoo.com - May 18 at 10:00 AM
Traders Buy High Volume of Call Options on Abaxis (ABAX)Traders Buy High Volume of Call Options on Abaxis (ABAX)
www.americanbankingnews.com - May 18 at 7:41 AM
Reviewing OYO Geospace (GEOS) and Abaxis (ABAX)Reviewing OYO Geospace (GEOS) and Abaxis (ABAX)
www.americanbankingnews.com - May 17 at 5:10 PM
Abaxis (ABAX) Upgraded at ValuEngineAbaxis (ABAX) Upgraded at ValuEngine
www.americanbankingnews.com - May 17 at 4:17 PM
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Abaxis, Inc. - ABAXSHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Abaxis, Inc. - ABAX
finance.yahoo.com - May 17 at 9:37 AM
Zoetis (ZTS) Inks Deal to Acquire Abaxis for $2 BillionZoetis (ZTS) Inks Deal to Acquire Abaxis for $2 Billion
www.zacks.com - May 17 at 9:37 AM
Abaxis (ABAX) Upgraded to Neutral by Credit Suisse GroupAbaxis (ABAX) Upgraded to Neutral by Credit Suisse Group
www.americanbankingnews.com - May 16 at 6:07 PM
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Abaxis, Inc.ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Abaxis, Inc.
finance.yahoo.com - May 16 at 4:34 PM
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Abaxis, Inc. (ABAX) on Behalf of Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating the Board of Directors of Abaxis, Inc. (ABAX) on Behalf of Stockholders and Encourages Investors to Contact the Firm
www.businesswire.com - May 16 at 4:34 PM
REFILE-UPDATE 5-Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 blnREFILE-UPDATE 5-Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 bln
www.cnbc.com - May 16 at 4:34 PM
Abaxis (ABAX) Downgraded by SidotiAbaxis (ABAX) Downgraded by Sidoti
www.americanbankingnews.com - May 16 at 10:30 AM
Zoetis to Buy Veterinary-Diagnostics Company Abaxis for $2 BillionZoetis to Buy Veterinary-Diagnostics Company Abaxis for $2 Billion
www.wsj.com - May 16 at 9:37 AM
Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 blnZoetis to buy veterinary diagnostics firm Abaxis for $1.9 bln
finance.yahoo.com - May 16 at 9:37 AM
BRIEF-Zoetis Says Upon Deal Termination By Abaxis Or Co, Termination Fee Of $70 Mln May Be Payable By AbaxisBRIEF-Zoetis Says Upon Deal Termination By Abaxis Or Co, Termination Fee Of $70 Mln May Be Payable By Abaxis
www.reuters.com - May 16 at 9:37 AM
Zoetis To Buy Abaxis In $2 Billion DealZoetis To Buy Abaxis In $2 Billion Deal
www.msn.com - May 16 at 9:37 AM
Zoetis to Acquire Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic InstrumentsZoetis to Acquire Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments
finance.yahoo.com - May 16 at 9:37 AM
Zoetis to buy veterinary diagnostics company Abaxis for $2bnZoetis to buy veterinary diagnostics company Abaxis for $2bn
www.ft.com - May 16 at 9:37 AM
[$$] Zoetis to Buy Abaxis for $2 Billion[$$] Zoetis to Buy Abaxis for $2 Billion
finance.yahoo.com - May 16 at 9:36 AM
Abaxis (ABAX) Alert: Johnson Fistel Investigates Proposed Sale of Abaxis, Inc.; Are Shareholders Getting a Fair Deal?Abaxis (ABAX) Alert: Johnson Fistel Investigates Proposed Sale of Abaxis, Inc.; Are Shareholders Getting a Fair Deal?
finance.yahoo.com - May 16 at 9:36 AM
Abaxis (ABAX) Director Sells $408,360.00 in StockAbaxis (ABAX) Director Sells $408,360.00 in Stock
www.americanbankingnews.com - May 10 at 7:54 PM
Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2018 Health Care Conference and the UBS Global Healthcare ConferenceAbaxis, Inc. to Present at the Bank of America Merrill Lynch 2018 Health Care Conference and the UBS Global Healthcare Conference
finance.yahoo.com - May 10 at 9:34 AM
Research Report Identifies Jaguar Animal Health, Dollar Tree, WPX Energy ...Research Report Identifies Jaguar Animal Health, Dollar Tree, WPX Energy ...
globenewswire.com - May 7 at 4:42 PM
Abaxis (ABAX) Receives Consensus Rating of "Hold" from BrokeragesAbaxis (ABAX) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 6 at 8:16 PM
Abaxis (ABAX) Expected to Announce Quarterly Sales of $67.84 MillionAbaxis (ABAX) Expected to Announce Quarterly Sales of $67.84 Million
www.americanbankingnews.com - May 6 at 4:15 AM
Analyzing OYO Geospace (GEOS) & Abaxis (ABAX)Analyzing OYO Geospace (GEOS) & Abaxis (ABAX)
www.americanbankingnews.com - May 6 at 1:10 AM
Zacks: Brokerages Expect Abaxis (ABAX) to Announce $0.35 Earnings Per ShareZacks: Brokerages Expect Abaxis (ABAX) to Announce $0.35 Earnings Per Share
www.americanbankingnews.com - May 4 at 11:30 AM
Form 4 ABAXIS INC For: Apr 30 Filed by: ARON KENNETHForm 4 ABAXIS INC For: Apr 30 Filed by: ARON KENNETH
www.streetinsider.com - May 3 at 9:14 AM
Abaxis (ABAX) Stock Rating Lowered by Zacks Investment ResearchAbaxis (ABAX) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 30 at 11:40 AM
Edited Transcript of ABAX earnings conference call or presentation 26-Apr-18 8:15pm GMTEdited Transcript of ABAX earnings conference call or presentation 26-Apr-18 8:15pm GMT
finance.yahoo.com - April 28 at 9:47 AM
Abaxis (ABAX) Beats Earnings and Revenue Estimates in Q4Abaxis (ABAX) Beats Earnings and Revenue Estimates in Q4
finance.yahoo.com - April 27 at 4:31 PM
Stifel Nicolaus Increases Abaxis (ABAX) Price Target to $62.00Stifel Nicolaus Increases Abaxis (ABAX) Price Target to $62.00
www.americanbankingnews.com - April 27 at 11:23 AM
Abaxis: Fiscal 4Q Earnings SnapshotAbaxis: Fiscal 4Q Earnings Snapshot
www.cnbc.com - April 27 at 9:55 AM
ABAXIS (ABAX) Q4 2018 Results - Earnings Call TranscriptABAXIS (ABAX) Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - April 27 at 9:55 AM
BRIEF-Abaxis Reports Q4 EPS Of $0.43BRIEF-Abaxis Reports Q4 EPS Of $0.43
www.reuters.com - April 27 at 9:55 AM
Abaxis (ABAX) Releases  Earnings Results, Beats Expectations By $0.10 EPSAbaxis (ABAX) Releases Earnings Results, Beats Expectations By $0.10 EPS
www.americanbankingnews.com - April 26 at 5:16 PM
Abaxis (ABAX) Increases Dividend to $0.18 Per ShareAbaxis (ABAX) Increases Dividend to $0.18 Per Share
www.americanbankingnews.com - April 26 at 4:40 PM
A Preview Of Abaxis Q4 EarningsA Preview Of Abaxis Q4 Earnings
finance.yahoo.com - April 26 at 4:32 PM
Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2018 and Declares a 13% Increase in Quarterly Cash DividendAbaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2018 and Declares a 13% Increase in Quarterly Cash Dividend
finance.yahoo.com - April 26 at 4:32 PM
Head-To-Head Comparison: Abaxis (ABAX) versus Cubic (CUB)Head-To-Head Comparison: Abaxis (ABAX) versus Cubic (CUB)
www.americanbankingnews.com - April 25 at 7:18 PM
LabCorp (LH) Beats on Q1 Earnings, Revenues, Lifts '18 ViewLabCorp (LH) Beats on Q1 Earnings, Revenues, Lifts '18 View
finance.yahoo.com - April 25 at 4:41 PM
Abaxis To Report Fourth Quarter And Fiscal Year 2018 Financial Results On Thursday, April 26, 2018Abaxis To Report Fourth Quarter And Fiscal Year 2018 Financial Results On Thursday, April 26, 2018
finance.yahoo.com - April 20 at 9:34 AM
$67.03 Million in Sales Expected for Abaxis (ABAX) This Quarter$67.03 Million in Sales Expected for Abaxis (ABAX) This Quarter
www.americanbankingnews.com - April 19 at 4:27 AM
Abbott (ABT) Q1 Earnings & Revenues Top, '18 View RetainedAbbott (ABT) Q1 Earnings & Revenues Top, '18 View Retained
finance.yahoo.com - April 18 at 4:48 PM
Abaxis (ABAX) to Release Earnings on WednesdayAbaxis (ABAX) to Release Earnings on Wednesday
www.americanbankingnews.com - April 18 at 1:52 AM
$0.32 Earnings Per Share Expected for Abaxis (ABAX) This Quarter$0.32 Earnings Per Share Expected for Abaxis (ABAX) This Quarter
www.americanbankingnews.com - April 17 at 8:00 AM
Abaxis (ABAX) Downgraded by Zacks Investment Research to "Sell"Abaxis (ABAX) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - April 15 at 8:37 AM

SEC Filings

Abaxis (NASDAQ:ABAX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Abaxis (NASDAQ:ABAX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Abaxis (NASDAQ ABAX) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.